Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer.

Liveringhouse, Casey; Sim, Austin; Yamoah, Kosj; Poch, Michael; Wilder, Richard B; Pow-Sang, Julio; Johnstone, Peter A S

Liveringhouse, Casey; Sim, Austin; Yamoah, Kosj; Poch, Michael; Wilder, Richard B; Pow-Sang, Julio; Johnstone, Peter A S.

Afiliação

Liveringhouse C; Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States.
Sim A; Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States.
Yamoah K; Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States.
Poch M; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States.
Wilder RB; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States.
Pow-Sang J; Oncology Analytics, Plantation, United States.
Johnstone PAS; Department of Genitourinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States.

Rep Pract Oncol Radiother ; 26(2): 188-195, 2021.

Article em En | MEDLINE | ID: mdl-34211768

Palavras-chave

high risk prostate cancer; prostatectomy; stereotactic radiotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Rep Pract Oncol Radiother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Polônia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google